| Literature DB >> 35878256 |
Chia-Chen Wu1, Jessica R Blount2, Alex Haimbaugh2,3, Samantha Heldman2,3, Jeremiah N Shields2, Tracie R Baker1,2,3.
Abstract
Urban environments are plagued by complex mixtures of anthropogenic volatile organic compounds (VOCs), such as mixtures of benzene, toluene, ethylene, and xylene (BTEX). Sources of BTEX that drive human exposure include vehicle exhaust, industrial emissions, off-gassing of building material, as well as oil spillage and leakage. Among the BTEX mixture, benzene is the most volatile compound and has been linked to numerous adverse health outcomes. However, few studies have focused on the effects of low-level benzene on exposure during early development, which is a susceptible window when hematological, immune, metabolic, and detoxification systems are immature. In this study, we used zebrafish to conduct a VOC exposure model and evaluated phenotypic and transcriptomic responses following 0.1 and 1 ppm benzene exposure during the first five days of embryogenesis (n = 740 per treatment). The benzene body burden was 2 mg/kg in 1 ppm-exposed larval zebrafish pools and under the detection limit in 0.1 ppm-exposed fish. No observable phenotypic changes were found in both larvae except for significant skeletal deformities in 0.1 ppm-exposed fish (p = 0.01) compared with unexposed fish. Based on transcriptomic responses, 1 ppm benzene dysregulated genes that were implicated with the development of hematological system, and the regulation of oxidative stress response, fatty acid metabolism, immune system, and inflammatory response, including apob, nfkbiaa, serpinf1, foxa1, cyp2k6, and cyp2n13 from the cytochrome P450 gene family. Key genes including pik3c2b, pltp, and chia.2 were differentially expressed in both 1 and 0.1 ppm exposures. However, fewer transcriptomic changes were induced by 0.1 ppm compared with 1 ppm. Future studies are needed to determine if these transcriptomic responses during embryogenesis have long-term consequences at levels equal to or lower than 1 ppm.Entities:
Keywords: benzene; transcriptomics; volatile organic compounds; zebrafish
Year: 2022 PMID: 35878256 PMCID: PMC9324908 DOI: 10.3390/toxics10070351
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Figure 1Phenotypic responses following benzene exposure from 4 h post-fertilization (hpf) to 5 days post-fertilization (dpf). (a) Average mortality (left) and hatch rate (right) of live embryos over the course of exposure period (n = 740 per treatment); (b) percentage of embryos with morphological abnormalities at 5 dpf per treatment (n = 134, 149, 146 for 0, 0.1, and 1 ppm benzene); or (c) average distance moved by larval zebrafish during light and dark cycles (n = 32 per treatment). * Condition is significantly different from control (0 ppm; p < 0.05).
Figure 2Transcriptomic responses following benzene exposure from 4 h post-fertilization to 5 days post-fertilization (dpf). (a) Venn diagram of the number of differentially expressed genes (DEGs) upregulated or downregulated at 0.1, 1 ppm, and both; and (b) number of DEGs implicated in top-rank canonical pathways.
Dysregulated genes of benzene exposure based on gene expression fold changes relative to unexposed controls.
| Gene Symbol | Gene Name | 1 ppm | 0.1 ppm |
|---|---|---|---|
|
| |||
|
| Phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta | 2.8 | 1.85 |
|
| Meprin A, alpha (PABA peptide hydrolase), tandem duplicate 2 | 1.7 | 1.73 |
|
| Acidic chitinase 2 | 2.01 | 1.90 |
|
| Cholinergic receptor, nicotinic, beta 2 | 0.59 | 0.54 |
|
| Phospholipid transfer protein | 0.57 | 0.58 |
|
| Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha a | 1.70 | |
|
| Apolipoprotein B | 1.70 | |
|
| Orthologous to human c2, complement c2 | 1.70 | |
|
| Complement C3a, tandem duplicate 3 | 2.16 | |
|
| Interleukin 15 | 0.49 | |
|
| Interferon induced with helicase C domain 1 | 0.54 | |
|
| Mitogen-activated protein kinase 11 | 0.58 | |
|
| |||
|
| Acyl-CoA dehydrogenase family, member 11 | 3.20 | |
|
| ANTXR cell adhesion molecule 2 | 0.49 | |
|
| Gamma-aminobutyric acid type A receptor subunit beta1 | 0.58 | |
|
| HIC ZBTB transcriptional repressor 1 | 1.72 | |
|
| Heat shock protein 90, alpha (cytosolic), class A member 1, tandem duplicate 1 | 1.82 | |
|
| Kinesin family member 21B | 2.12 | |
|
| Solute carrier family 27 member 2 | 1.72 | |
|
| Solute carrier family 9 member A5 | 0.56 | |
|
| Lanthionine synthetase C-like 2 | 0.59 | |
|
| |||
|
| Mitochondrial trans-2-enoyl-CoA reductase | 2.14 | 1.97 |
|
| Cytochrome P450, family 2, subfamily K, polypeptide 6 | 1.72 | |
|
| Cytochrome P450, family 2, subfamily N, polypeptide 13 | 1.84 | |
|
| 3-hydroxy-3-methylglutaryl-CoA reductase a | 1.94 | |
|
| Serpin family F member 1 | 1.84 | |
|
| |||
|
| TAF4A RNA polymerase II, TATA box binding protein (TBP)-associated factor | 0.50 | 0.52 |
|
| Forkhead box A2 | 1.74 | |
|
| Tachykinin receptor 1a | 0.58 | |